Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

For HIV-infected children, formulation development, pharmacokinetic (PK) data, and evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence of efficacy in children may not be needed if acceptable safety and PK parameters are demonstrated in children. However,...

Full description

Saved in:
Bibliographic Details
Main Authors: Deborah Ford, Rebecca Turner, Anna Turkova, Martina Penazzato, Victor Musiime, Mutsa Bwakura-Dangarembizi, Avy Violari, Chishala Chabala, Thanyawee Puthanakit, Tavitiya Sudjaritruk, Tim R. Cressey, Marc Lallemant, Diana M. Gibb
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055149780&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/62807
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University